EUVIMEDOpdag EUVIMED
Crossref

Apoptosis Induction by Benzhydrol-Acetamide in Acute Myeloid Leukaemia Kasumi-1 Cells

Ghazal Abdullahi Olawale, Nozlena Abdul Samad, Mohamad Nurul Azmi, Muath Hekmat Helal, Nor Adlin Yusoff, Melissa Kilus, Hasan Mohammad Abumahmoud

Journal of Pioneering Medical Sciences · 2026-11-05 · 15 (10) · 104-113

DOI: 10.47310/jpms2026151010 ↗

At a glance

Journal article in Journal of Pioneering Medical Sciences, published online on 2026-11-05. Written by Ghazal Abdullahi Olawale and 6 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The development of effective anticancer agents is challenging due to toxicity, drug resistance and poor physicochemical properties of current compounds. We synthesised a novel benzhydrol derivative, (4-acetamido(phenyl)phenyl) methyl acetate, through a two-step reduction-acylation process from 4-aminobenzophenone. Structural confirmation was validated via NMR spectroscopy. The compound's cytotoxic potential was evaluated against acute myeloid leukaemia (Kasumi-1) and normal haematopoietic stem cell (CD34+) lines using the MTT assay. The compound showed a time- and concentration-dependent decrease in Kasumi-1 cell viability, with an IC₅₀ of 21.30±2.47 µg/mL (p<0.0001) at 72 h (~74 µM), indicating moderate effectiveness against Kasumi-1 cells. No significant effect was observed on CD34+ cells; a selectivity index greater than 2.56 indicates substantial selectivity of the compound for cancer cells. In silico predictions indicated the compound's potential to interact with key apoptosis-related proteins. Morphological studies indicated apoptosis-related changes in Kasumi-1 cells, corroborating cytotoxic findings, further validated by flow cytometry and protein expression analyses. These findings highlight the pharmacological potential of (4-acetamido(phenyl)phenyl) methyl acetate, suggesting further chemical modifications to improve anticancer activity and pharmacokinetic properties. Additional mechanistic studies and evaluations in various cancer models are necessary to confirm its therapeutic potential.

Cite

APA

Olawale, G. A., Samad, N. A., Azmi, M. N., Helal, M. H., Yusoff, N. A., Kilus, M., & Abumahmoud, H. M. (2026). Apoptosis Induction by Benzhydrol-Acetamide in Acute Myeloid Leukaemia Kasumi-1 Cells. Journal of Pioneering Medical Sciences, 15(10), 104-113. https://doi.org/10.47310/jpms2026151010

Vancouver

Olawale GA, Samad NA, Azmi MN, Helal MH, Yusoff NA, Kilus M, et al. Apoptosis Induction by Benzhydrol-Acetamide in Acute Myeloid Leukaemia Kasumi-1 Cells. Journal of Pioneering Medical Sciences. 2026;15(10):104-113. doi:10.47310/jpms2026151010

BibTeX
@article{Olawale2026,
  author = {Olawale, Ghazal Abdullahi and Samad, Nozlena Abdul and Azmi, Mohamad Nurul and Helal, Muath Hekmat and Yusoff, Nor Adlin and Kilus, Melissa and Abumahmoud, Hasan Mohammad},
  title = {Apoptosis Induction by Benzhydrol-Acetamide in Acute Myeloid Leukaemia Kasumi-1 Cells},
  journal = {Journal of Pioneering Medical Sciences},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {104--113},
  doi = {10.47310/jpms2026151010}
}
Start for free →